Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

10x Genomics (TXG) Receivables - Other (2024 - 2025)

10x Genomics' Receivables - Other history spans 2 years, with the latest figure at $35.5 million for Q4 2025.

  • For Q4 2025, Receivables - Other rose 5754.79% year-over-year to $35.5 million; the TTM value through Dec 2025 reached $35.5 million, up 5754.79%, while the annual FY2025 figure was $35.5 million, 5754.79% up from the prior year.
  • Receivables - Other for Q4 2025 was $35.5 million at 10x Genomics, down from $52.8 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $69.1 million in Q2 2025 and bottomed at $606000.0 in Q4 2024.